Cargando…

NK Cell-Mediated Eradication of Ovarian Cancer Cells with a Novel Chimeric Antigen Receptor Directed against CD44

Ovarian cancer is the most common cause of gynecological cancer-related death in the developed world. Disease recurrence and chemoresistance are major causes of poor survival rates in ovarian cancer patients. Ovarian cancer stem cells (CSCs) were shown to represent a source of tumor recurrence owing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klapdor, Rüdiger, Wang, Shuo, Morgan, Michael A., Zimmermann, Katharina, Hachenberg, Jens, Büning, Hildegard, Dörk, Thilo, Hillemanns, Peter, Schambach, Axel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533227/ https://www.ncbi.nlm.nih.gov/pubmed/34680456 http://dx.doi.org/10.3390/biomedicines9101339

Ejemplares similares

Characterization of a Novel Third-Generation Anti-CD24-CAR against Ovarian Cancer
por: Klapdor, Rüdiger, et al.
Publicado: (2019)

Use of Cell and Genome Modification Technologies to Generate Improved “Off-the-Shelf” CAR T and CAR NK Cells
por: Morgan, Michael A., et al.
Publicado: (2020)

Towards Novel Gene and Cell Therapy Approaches for Cervical Cancer
por: Polten, Robert, et al.
Publicado: (2022)

Tumor Organoid and Spheroid Models for Cervical Cancer
por: Kutle, Ivana, et al.
Publicado: (2023)

Skeletal muscle-directed gene therapy: hijacking the fusogenic properties of muscle cells
por: Büning, Hildegard, et al.
Publicado: (2023)

Analyzing the Genotoxicity of Retroviral Vectors in Hematopoietic Cell Gene Therapy
por: Biasco, Luca, et al.
Publicado: (2017)

Improved Activity against Acute Myeloid Leukemia with Chimeric Antigen Receptor (CAR)-NK-92 Cells Designed to Target CD123
por: Morgan, Michael A., et al.
Publicado: (2021)

Development and characterisation of NKp44‐based chimeric antigen receptors that confer T cells with NK cell‐like specificity
por: Kasahara, Yasushi, et al.
Publicado: (2020)

Gene therapy on the move
por: Kaufmann, Kerstin B, et al.
Publicado: (2013)

Development of Automated Separation, Expansion, and Quality Control Protocols for Clinical-Scale Manufacturing of Primary Human NK Cells and Alpharetroviral Chimeric Antigen Receptor Engineering
por: Oberschmidt, Olaf, et al.
Publicado: (2019)

DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy
por: Cifaldi, Loredana, et al.
Publicado: (2023)

CAR-NK Cells: A Chimeric Hope or a Promising Therapy?
por: Sabbah, Mohamad, et al.
Publicado: (2022)

CAR-NK Cells Targeting HER1 (EGFR) Show Efficient Anti-Tumor Activity against Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Nowak, Juliette, et al.
Publicado: (2023)

NK Cells Armed with Chimeric Antigen Receptors (CAR): Roadblocks to Successful Development
por: Bashiri Dezfouli, Ali, et al.
Publicado: (2021)

Generation of an NFκB-Driven Alpharetroviral “All-in-One” Vector Construct as a Potent Tool for CAR NK Cell Therapy
por: Rudek, Loreen Sophie, et al.
Publicado: (2021)

NK Cells Equipped With a Chimeric Antigen Receptor That Overcomes Inhibition by HLA Class I for Adoptive Transfer of CAR-NK Cells
por: Zhuang, Xiaoxuan, et al.
Publicado: (2022)

Gene therapy enters the pharma market: The short story of a long journey
por: Büning, Hildegard
Publicado: (2013)

Generation of NK cells with chimeric-switch receptors to overcome PD1-mediated inhibition in cancer immunotherapy
por: Susek, Katharina H., et al.
Publicado: (2022)

Chimeric Antigen Receptor T Cells Targeting Cell Surface GRP78 to Eradicate Acute Myeloid Leukemia
por: Yu, Wei, et al.
Publicado: (2022)

Harnessing NK cells for cancer immunotherapy: immune checkpoint receptors and chimeric antigen receptors
por: Kim, Nayoung, et al.
Publicado: (2021)

A modifiable universal cotinine-chimeric antigen system of NK cells with multiple targets
por: Kang, Hee Young, et al.
Publicado: (2023)

Chimeric antigen receptors in the brain: Can we tackle glioblastoma with engineered NK cells?
por: Roth, Patrick
Publicado: (2023)

CXCR5 guides migration and tumor eradication of anti-EGFR chimeric antigen receptor T cells
por: Li, Guangchao, et al.
Publicado: (2021)

Blocking the PCNA/NKp44 Checkpoint to Stimulate NK Cell Responses to Multiple Myeloma
por: Iraqi, Muhammed, et al.
Publicado: (2022)

Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy
por: Gong, Ying, et al.
Publicado: (2021)

Chimeric antigen receptor-engineered NK cells: new weapons of cancer immunotherapy with great potential
por: Wang, Xiao, et al.
Publicado: (2022)

Adeno-Associated Viral Vectors at the Frontier between Tolerance and Immunity
por: Mingozzi, Federico, et al.
Publicado: (2015)

Capsid Modifications for Targeting and Improving the Efficacy of AAV Vectors
por: Büning, Hildegard, et al.
Publicado: (2019)

Natural Killer Cells and Current Applications of Chimeric Antigen Receptor-Modified NK-92 Cells in Tumor Immunotherapy
por: Zhang, Jianguang, et al.
Publicado: (2019)

Chimeric antigen receptor engineered NK cellular immunotherapy overcomes the selection of T-cell escape variant cancer cells
por: Lee, Maxwell Y, et al.
Publicado: (2021)

Genetic Susceptibility to Endometrial Cancer: Risk Factors and Clinical Management
por: Dörk, Thilo, et al.
Publicado: (2020)

Conscription of Immune Cells by Light‐Activatable Silencing NK‐Derived Exosome (LASNEO) for Synergetic Tumor Eradication
por: Zhang, Mengjie, et al.
Publicado: (2022)

Characterization of patients with vulvar lichen sclerosus and association to vulvar carcinoma: a retrospective single center analysis
por: Steinkasserer, L., et al.
Publicado: (2022)

Towards Clinical Implementation of Adeno-Associated Virus (AAV) Vectors for Cancer Gene Therapy: Current Status and Future Perspectives
por: Hacker, Ulrich T., et al.
Publicado: (2020)

Recognition and Regulation of T Cells by NK Cells
por: Pallmer, Katharina, et al.
Publicado: (2016)

Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cells
por: Robbins, Yvette, et al.
Publicado: (2020)

You Have Got a Fast CAR: Chimeric Antigen Receptor NK Cells in Cancer Therapy
por: Pfefferle, Aline, et al.
Publicado: (2020)

CD19/CD22 bispecific chimeric antigen receptor‑NK‑92 cells are developed and evaluated
por: Kim, Hyori, et al.
Publicado: (2023)

Association of preoperative cone biopsy with recurrences after radical hysterectomy
por: Klapdor, Rüdiger, et al.
Publicado: (2021)

Next Generation CD44v6-Specific CAR-NK Cells Effective against Triple Negative Breast Cancer
por: Raftery, Martin J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_17sh5afdnr5soja42nr6acpo6l